2024
Characterizing Cannabis Use and Perceived Benefit in a Tertiary Headache Center Patient Sample
Starkey B, Pearlson G, Bond D, Glaser C, Bhargava A, Grosberg B, Verhaak A. Characterizing Cannabis Use and Perceived Benefit in a Tertiary Headache Center Patient Sample. Neurology Clinical Practice 2024, 14: e200285. PMID: 38455123, PMCID: PMC10915819, DOI: 10.1212/cpj.0000000000200285.Peer-Reviewed Original ResearchCannabis useCannabis productsCannabis-based productsBenefits of cannabis useCannabis use patternsRisk factorsClinical featuresMigraine managementCannabisSleep concernsPatient samplesMigraine headache characteristicsTertiary headache centerTreatment of migraineMigraine preventionHeadache centerMedication amountsMigraine characteristicsHeadache characteristicsMigraine symptomsPatient populationPerceived improvementHeadache treatmentPerceived benefitsParticipants
1993
Dopamine D2 receptor density estimates in schizophrenia: A positron emission tomography study with11C-N-methylspiperone
Tune L, Wong D, Pearlson G, Strauss M, Young T, Shaya E, Dannals R, Wilson A, Ravert H, Sapp J, Cooper T, Chase G, Wagner H. Dopamine D2 receptor density estimates in schizophrenia: A positron emission tomography study with11C-N-methylspiperone. Psychiatry Research 1993, 49: 219-237. PMID: 7909948, DOI: 10.1016/0165-1781(93)90063-m.Peer-Reviewed Original ResearchConceptsPositron emission tomographySchizophrenic patientsBmax valuesEntire groupControl subjectsEmission tomographyDopamine D2 receptor densityNeuroleptic-free patientsDuration of illnessChronic schizophrenic patientsD2 receptor densityClinical characteristicsPatient populationReceptor abnormalitiesCorpus striatumClinical dataReceptor densityPatientsControl groupFunction of ageLate manifestationDifferent radioligandsFour-compartment modelSignificant differencesRadioligand